Zura Bio (ZURA) | Stock Overview & Key Data
Zura Bio Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $37.55 on March 20, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Zura Bio
ZURA
|
536.08M Small-cap | 4.25% | -22.03% | -41.40% | -9.58% | -33.69% | 208.33% | -60.97% | -61.86% | -61.86% | -61.86% | -61.86% |
|
Vertex
VRTX
|
109.45B Large-cap | 1.69% | 3.09% | -3.36% | -1.15% | -0.37% | -2.31% | 27.89% | 136.85% | 413.01% | 888.51% | 1,245.83% |
|
Regeneron
REGN
|
80.98B Large-cap | 0.60% | -11.93% | -18.75% | -18.29% | -20.78% | 15.66% | -21.83% | 13.80% | 72.82% | 1,033.17% | 4,804.97% |
|
Adaptive
ADPT
|
2.13B Mid-cap | 8.83% | 18.51% | 58.40% | 28.26% | 44.06% | 70.54% | 109.77% | -55.39% | -63.56% | -63.56% | -63.56% |
|
Zymeworks
ZYME
|
1.96B Small-cap | -2.80% | -2.80% | -1.52% | -10.44% | -12.62% | 80.58% | 181.77% | -36.88% | 76.00% | 76.00% | 76.00% |
|
Agios
AGIO
|
1.48B Small-cap | -3.93% | 9.18% | 12.72% | 48.46% | 45.73% | -14.11% | 14.27% | -51.27% | -37.95% | 3.26% | 3.26% |
Ownership & Short Interest
Calculate Your Zura Bio Investment Returns
Long-Term Investment Performance Analysis
Zura Bio stock price in Aug 2021 was $9.70, A $1,000.00 lump sum investment in Zura Bio made 4 years ago would be worth approximately $379.38 today, representing a negative return of -62.06%. This translates to an annualized return (CAGR) of -18.31%.
4 Years 9 Months Investment Scenario (Aug 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ZURA's 52-week high and low?
- In the last 52 weeks, Zura Bio reached a high of $7.44 (on March 10, 2026) and a low of $1.00 (on July 1, 2025).
- What is the market cap and P/E ratio for ZURA?
- Curious about Zura Bio's size and valuation? Its market capitalization stands at 536.08M. When it comes to valuation, the P/E ratio (trailing twelve months) is 7.95, and the forward P/E (looking ahead) is -56.50.
- Does ZURA pay dividends? If so, what's the yield?
- As for dividends, Zura Bio isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Zura Bio's main competitors or similar companies to consider before investing?
When looking at Zura Bio, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX109.45B Healthcare Biotechnology -2.31% 27.89% Regeneron
REGN80.98B Healthcare Biotechnology 15.66% -21.83% Adaptive
ADPT2.13B Healthcare Biotechnology 70.54% 109.77% Zymeworks
ZYME1.96B Healthcare Biotechnology 80.58% 181.77% Agios
AGIO1.48B Healthcare Biotechnology -14.11% 14.27% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Zura Bio Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Zura Bio's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -52.49%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ZURA?
- Looking at Zura Bio's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of ZURA stock is held by insiders and institutions?
- Wondering who owns Zura Bio stock? Company insiders (like executives and directors) hold about 21.12% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 56.42%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.